9W7O
Crystal Structure of Taniborbactam in complex with SME-1 class A Carbapenemase
Summary for 9W7O
| Entry DOI | 10.2210/pdb9w7o/pdb |
| Descriptor | Beta-lactamase SME-1, (3~{R})-3-[2-[4-(2-azanylethylamino)cyclohexyl]ethanoylamino]-2-oxidanyl-3,4-dihydro-1,2-benzoxaborinine-8-carboxylic acid, TETRAETHYLENE GLYCOL, ... (4 entities in total) |
| Functional Keywords | boronic acid based transition state analogue (batsa), hydrolase |
| Biological source | Serratia marcescens |
| Total number of polymer chains | 2 |
| Total formula weight | 59939.32 |
| Authors | Dhankhar, K.,Hazra, S. (deposition date: 2025-08-06, release date: 2025-11-19, Last modification date: 2026-03-11) |
| Primary citation | Dhankhar, K.,Hazra, M.,Nair, A.S.R.,Alhmeidi Alkhatib, A.E.,Mishra, N.C.,Hazra, S. Beyond structure and activity: targeting class A carbapenemases with monocyclic and bicyclic boronic acids to counter antimicrobial resistance. Org.Biomol.Chem., 24:1595-1599, 2026 Cited by PubMed Abstract: Bicyclic boronic acids inhibit SME-1 carbapenemase a unique π-π stacking with His105 and covalent interaction with Ser70. Ledaborbactam shows the strongest inhibition, with the lowest and enhanced structural stability. X-ray crystallography and molecular dynamics reveal key features helpful in structure-based optimization of boronates targeting class A β-lactamases. PubMed: 41217385DOI: 10.1039/d5ob01703c PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.93 Å) |
Structure validation
Download full validation report






